+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Lymphoma Therapeutics Market by Treatment, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Lymphoma Therapeutics Market by Treatment, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 196 Pages
  • Global
From
Non-Hodgkin Lymphoma Treatment Market by Treatment Type, Application, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Non-Hodgkin Lymphoma Treatment Market by Treatment Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 183 Pages
  • Global
From
Castleman Disease Treatment Market by Disease Type, Indication, Treatment, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Castleman Disease Treatment Market by Disease Type, Indication, Treatment, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Global Forecast 2025-2030 - Product Thumbnail Image

Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Global Forecast 2025-2030

  • Report
  • October 2024
  • 186 Pages
  • Global
From
Ovarian Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Autologous Stem Cell and Non-Stem Cell-based Therapies Market by Type, Application, End-user, and Regional Outlook - Forecast to 2030 - Product Thumbnail Image

Global Autologous Stem Cell and Non-Stem Cell-based Therapies Market by Type, Application, End-user, and Regional Outlook - Forecast to 2030

  • Report
  • November 2023
  • 86 Pages
  • Global
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma (Dlbcl) Therapeutics Market 2024-2028 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma (Dlbcl) Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 177 Pages
  • Global
From
Multiple Myeloma Market Report, Forecast by Drugs Types, Disease Types, End User, Countries and Company Analysis, 2024-2032 - Product Thumbnail Image

Multiple Myeloma Market Report, Forecast by Drugs Types, Disease Types, End User, Countries and Company Analysis, 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Review, H1 2020 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1667 Pages
  • Global
From
Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 277 Pages
  • Global
From
Colorectal Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Colorectal Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gardner Syndrome Treatment Global Market Report 2024 - Product Thumbnail Image

Gardner Syndrome Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography - Product Thumbnail Image

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

  • Report
  • October 2023
  • 204 Pages
  • Global
From
Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030 - Product Thumbnail Image

Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030

  • Report
  • October 2024
  • 197 Pages
  • Global
From
Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 156 Pages
  • Global
From
Cystic Fibrosis (CF) Therapy Area Report - Product Thumbnail Image

Cystic Fibrosis (CF) Therapy Area Report

  • Report
  • November 2021
  • 51 Pages
  • Global
Engineered T Cells Market by Type (Chimeric Antigen Receptor Modified T Cells, T Cells Receptor Modified T Cells and Tumor Infiltrating Lymphocytes), Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030 - Product Thumbnail Image

Engineered T Cells Market by Type (Chimeric Antigen Receptor Modified T Cells, T Cells Receptor Modified T Cells and Tumor Infiltrating Lymphocytes), Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030

  • Report
  • February 2022
  • 227 Pages
  • Global
From
Loading Indicator